Diagnos Inc.

Diagnos Inc.

February 23, 2010 10:52 ET

DIAGNOS Named to the 2010 TSX Venture 50®

BROSSARD, QUEBEC, CANADA --(Marketwire - Feb. 23, 2010) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, announces today that it was named to the 2010 TSX Venture 50®, a ranking of strong performers listed on TSX Venture Exchange.

"Being named to the TSX Venture 50 for the first time in 2008 and now in 2010 is a tremendous recognition of our accomplishments to date. The TSX Venture is an ideal companion in helping our company develop new products and address new markets. Recently, DIAGNOS has launched a promising new technology called CARA (Computer Assisted Retinal analysis), a simple and affordable service for a fast and accurate assessment of the retinal health of an individual. This new service clearly reflects our mission to use our proprietary artificial intelligence algorithms to help companies and self-employed individuals faced with complex decision-making challenges," said André Larente, President and CEO of DIAGNOS.

"We are pleased to announce the 2010 TSX Venture 50", said John McCoach, President, TSX Venture Exchange. "These outstanding companies are proven leaders in their respective sectors and we are proud to have them listed on TSX Venture Exchange. We wish them all continued success."

TSX Venture 50® is comprised of 10 emerging companies in five industry sectors that have been identified as leaders in Canada's public venture market. These companies were selected based on four equally weighted criteria that include return on investment, trading, analyst coverage and market capitalization growth in Cleantech, Diversified Industries, Mining, Oil & Gas and Technology and Life Sciences sectors.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK) with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision-making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

The information contained herein is for information purposes only and is not an invitation to purchase securities listed on TSX Venture Exchange and/or Toronto Stock Exchange. TMX Group Inc. and its affiliates do not endorse or recommend any securities referenced. You should not rely on the information contained herein for any trading, business or financial purposes. TMX Group Inc. and its affiliates assume no liability for any errors or inaccuracies herein or any use or reliance upon this information.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

Contact Information